Lewy Bodies

Lewy Bodies are abnormal aggregates of proteins that accumulate in the brain cells of those suffering from certain neurodegenerative disorders. These include Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. In Parkinson's disease, Lewy Bodies are found in a specific region of the brain that controls movement, called the substantia nigra. This leads to the characteristic symptoms of Parkinson's disease, such as tremors, stiffness, and difficulty with balance and coordination. In dementia with Lewy bodies, Lewy Bodies are found in multiple regions of the brain, contributing to cognitive and behavioral changes, including hallucinations and changes in mood and personality. Current treatments for these disorders focus on managing symptoms, rather than slowing or stopping the progression of the disease. However, ongoing research is exploring new ways to target Lewy Bodies and other disease-related proteins in order to prevent their accumulation or ultimately remove them from affected cells. Potential therapies include immunotherapy, which involves boosting the body's immune response to target specific proteins, and gene therapy, which involves introducing new genes into affected cells to prevent or reverse protein accumulation. Overall, understanding the role of Lewy Bodies in neurodegenerative diseases is a key area of ongoing research that has the potential to significantly improve the quality of life for those affected by these disorders.


From: Journal of Neurological Research And Therapy

Related Article For "Lewy Bodies"

About (3) results

Article:

Acquired Abnormalities of Plasma Von Willebrand Factor Related Parameters and ADAMTS13 Autoantibodies in Aggressive Haematological Malignancies.

Journal:

Hematology and Oncology Research

Article:

Successful Allogeneic Hematopoietic Stem Cell Transplantation from A 5/10 Mismatched Unrelated Donor in A Patient with Donor-Specific Anti-HLA Antibodies.

Journal:

Hematology and Oncology Research

Article:

Presentation of Neutralizing Antibodies in Single- or Pooled-Convalescent Immune Plasma from Donors to Prevent the Current SARS-CoV-2 Pandemic

Journal:

International Journal of Coronaviruses